These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12053915)

  • 41. Pathogenicity of antigenic variants of Newcastle disease virus Italian strain selected with monoclonal antibodies.
    Meulemans G; Gonze M; Carlier MC; Petit P; Burny A; Long LE
    Ann Rech Vet; 1987; 18(4):371-4. PubMed ID: 2454065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathogenicity and immunogenicity of different recombinant Newcastle disease virus clone 30 variants after in ovo vaccination.
    Ramp K; Topfstedt E; Wäckerlin R; Höper D; Ziller M; Mettenleiter TC; Grund C; Römer-Oberdörfer A
    Avian Dis; 2012 Mar; 56(1):208-17. PubMed ID: 22545548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural features unique to each of the three antigenic sites on the hemagglutinin-neuraminidase protein of Newcastle disease virus.
    Gotoh B; Sakaguchi T; Nishikawa K; Inocencio NM; Hamaguchi M; Toyoda T; Nagai Y
    Virology; 1988 Mar; 163(1):174-82. PubMed ID: 2450424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protection from clinical disease against three highly virulent strains of Newcastle disease virus after in ovo application of an antibody-antigen complex vaccine in maternal antibody-positive chickens.
    Kapczynski DR; Martin A; Haddad EE; King DJ
    Avian Dis; 2012 Sep; 56(3):555-60. PubMed ID: 23050473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of Newcastle disease virus recombinant expressing avian influenza virus H6 hemagglutinin against Newcastle disease and low pathogenic avian influenza in chickens and turkeys.
    Schröer D; Veits J; Keil G; Römer-Oberdörfer A; Weber S; Mettenleiter TC
    Avian Dis; 2011 Jun; 55(2):201-11. PubMed ID: 21793434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine.
    Nagy E; Krell PJ; Dulac GC; Derbyshire JB
    Avian Dis; 1991; 35(3):585-90. PubMed ID: 1953580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection of chickens with a recombinant fowlpox virus expressing the Newcastle disease virus hemagglutinin-neuraminidase gene.
    Edbauer C; Weinberg R; Taylor J; Rey-Senelonge A; Bouquet JF; Desmettre P; Paoletti E
    Virology; 1990 Dec; 179(2):901-4. PubMed ID: 2173266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the use of monoclonal antibodies to hemagglutinin and fusion glycoproteins of Newcastle disease virus for virus identification and strain differentiation purposes.
    Meulemans G; Gonze M; Carlier MC; Petit P; Burny A; Le Long
    Arch Virol; 1987; 92(1-2):55-62. PubMed ID: 2432855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antigenic variation between Newcastle disease viruses of goose and chicken origin.
    Li ZJ; Li Y; Chang S; Ding Z; Mu LZ; Cong YL
    Arch Virol; 2010 Apr; 155(4):499-505. PubMed ID: 20204429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biological characterization of wild-bird-origin avian avulavirus 1 and efficacy of currently applied vaccines against potential infection in commercial poultry.
    El Naggar RF; Rohaim MA; Bazid AH; Ahmed KA; Hussein HA; Munir M
    Arch Virol; 2018 Oct; 163(10):2743-2755. PubMed ID: 29922856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of a novel VIIl sub-genotype of Newcastle disease virus circulating in Iran.
    Sabouri F; Vasfi Marandi M; Bashashati M
    Avian Pathol; 2018 Feb; 47(1):90-99. PubMed ID: 28874068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes.
    Firouzamandi M; Moeini H; Hosseini D; Bejo MH; Omar AR; Mehrbod P; Ideris A
    J Vet Sci; 2016 Mar; 17(1):21-6. PubMed ID: 27051336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Newcastle disease virus: is an updated attenuated vaccine needed?
    Shahar E; Haddas R; Goldenberg D; Lublin A; Bloch I; Bachner Hinenzon N; Pitcovski J
    Avian Pathol; 2018 Oct; 47(5):467-478. PubMed ID: 29897786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic characterization and evolutionary analysis of Newcastle disease virus isolated from domestic duck in South Korea.
    Gaikwad S; Kim JY; Lee HJ; Jung SC; Choi KS
    Gene; 2016 Mar; 579(1):34-40. PubMed ID: 26721461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two types of Newcastle disease viruses isolated from feral birds in western Australia detected by monoclonal antibodies.
    Alexander DJ; Mackenzie JS; Russell PH
    Aust Vet J; 1986 Nov; 63(11):365-7. PubMed ID: 3548691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic, antigenic, and pathogenic characteristics of Newcastle disease viruses isolated from geese in China.
    Xu Q; Sun J; Gao M; Zhao S; Liu H; Zhang T; Han Z; Kong X; Liu S
    J Vet Diagn Invest; 2017 Jul; 29(4):489-498. PubMed ID: 28548568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Newcastle disease virus outbreaks: vaccine mismatch or inadequate application?
    Dortmans JC; Peeters BP; Koch G
    Vet Microbiol; 2012 Nov; 160(1-2):17-22. PubMed ID: 22655976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity.
    Cardenas-Garcia S; Dunwoody RP; Marcano V; Diel DG; Williams RJ; Gogal RM; Brown CC; Miller PJ; Afonso CL
    PLoS One; 2016; 11(7):e0159153. PubMed ID: 27409587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.